SINCALIDE Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Sincalide, and what generic alternatives are available?

Sincalide is a drug marketed by Maia Pharms Inc and is included in one NDA. There are three patents protecting this drug.

This drug has three patent family members in three countries.

The generic ingredient in SINCALIDE is sincalide. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the sincalide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Sincalide

A generic version of SINCALIDE was approved as sincalide by MAIA PHARMS INC on November 22^nd, 2022.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for SINCALIDE?
What are the global sales for SINCALIDE?
What is Average Wholesale Price for SINCALIDE?

Summary for SINCALIDE

International Patents:	3
US Patents:	3
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	47
Clinical Trials:	4
Patent Applications:	1,477
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for SINCALIDE
What excipients (inactive ingredients) are in SINCALIDE?	SINCALIDE excipients list
DailyMed Link:	SINCALIDE at DailyMed

Drug patent expirations by year for SINCALIDE

Recent Clinical Trials for SINCALIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Bristol-Myers Squibb	Phase 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Phase 3
Penn State University	N/A

See all SINCALIDE clinical trials

Pharmacology for SINCALIDE

Drug Class	Cholecystokinin Analog

Anatomical Therapeutic Chemical (ATC) Classes for SINCALIDE

V04CC	Tests for bile duct patency
V04C	OTHER DIAGNOSTIC AGENTS
V04	DIAGNOSTIC AGENTS
V	Various

US Patents and Regulatory Information for SINCALIDE

SINCALIDE is protected by nine US patents.

Patents protecting SINCALIDE

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: DIAGNOSIS OF GALL BLADDER DISORDERS OR OTHER DIAGNOSTIC IMAGING BY STIMULATING GALLBLADDER CONTRACTION, AS MAY BE ASSESSED BY VARIOUS METHODS OF DIAGNOSTIC IMAGING, OR TO OBTAIN BY DUODENAL ASPIRATION A SAMPLE OF CONCENTRATED BILE FOR ANALYSIS

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: DIAGNOSIS OF PANCREATIC DISORDERS BY STIMULATING PANCREATIC SECRETION IN COMBINATION WITH SECRETIN PRIOR TO OBTAINING A DUODENAL ASPIRATE FOR ANALYSIS

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: DIAGNOSTIC IMAGING BY ACCELERATING THE TRAN IT OFA BARIUM MEAL THROUGH THE SMALL BOWEL, THEREBY DECREASING THE TIME AND EXTENT OF RADIATION ASSOCIATED WITH FLUOROSCOPY AND X-RAY EXAMINATION OF THE INTESTINAL TRACT

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ACCELERATE THE TRANSIT OF A BARIUM MEAL THROUGH THE SMALL BOWEL, THEREBY DECREASING THE TIME AND EXTENT OF RADIATION ASSOCIATED WITH FLUOROSCOPY AND X-RAY EXAMINATION OF THE INTESTINAL TRACT

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: STIMULATE GALLBLADDER CONTRACTION, AS MAY BE ASSESSED BY VARIOUS METHODS OF DIAGNOSTIC IMAGING, OR TO OBTAIN BY DUODENAL ASPIRATION A SAMPLE OF CONCENTRATED BILE FOR ANALYSIS

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: STIMULATE PANCREATIC SECRETION IN COMBINATION WITH SECRETIN PRIOR TO OBTAINING A DUODENAL ASPIRATE FOR ANALYSIS

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: STIMULATE GALLBLADDER CONTRACTION. AS MAY BE ASSESSED BY VARIOUS METHODS OF DIAGNOSTIC IMAGING, OR TO OBTAIN BY DUODENAL ASPIRATION A SAMPLE OF CONCENTRATED BILE FOR ANALYSIS

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: DIAGNOSIS OF GALL BLADDER DISORDERS BY STIMULATING GALLBLADDER CONTRACTION, AS MAY BE ASSESSED BY VARIOUS METHODS OF DIAGNOSTIC IMAGING, OR TO OBTAIN BY DUODENAL ASPIRATION A SAMPLE OF CONCENTRATED BILE FOR ANALYSIS

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Maia Pharms Inc	SINCALIDE	sincalide	POWDER;INTRAVENOUS	210850-001	Nov 22, 2022	AP	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Maia Pharms Inc	SINCALIDE	sincalide	POWDER;INTRAVENOUS	210850-001	Nov 22, 2022	AP	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Maia Pharms Inc	SINCALIDE	sincalide	POWDER;INTRAVENOUS	210850-001	Nov 22, 2022	AP	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for SINCALIDE

See the table below for patents covering SINCALIDE around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Canada	3073944	FORMULES DE SINCALIDE STABLES AU STOCKAGE (STORAGE STABLE SINCALIDE FORMULATIONS)	⤷ Sign Up
World Intellectual Property Organization (WIPO)	2019040904		⤷ Sign Up
European Patent Office	3672616	FORMULES DE SINCALIDE STABLES AU STOCKAGE (STORAGE STABLE SINCALIDE FORMULATIONS)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration